Short Interest in Semler Scientific, Inc. (NASDAQ:SMLR) Increases By 43.4%

Semler Scientific, Inc. (NASDAQ:SMLR) saw a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 1,280,000 shares, a growth of 43.4% from the November 15th total of 892,400 shares. Approximately 20.4% of the shares of the company are sold short. Based on an average trading volume of 485,000 shares, the days-to-cover ratio is presently 2.6 days.

Hedge Funds Weigh In On Semler Scientific

Institutional investors and hedge funds have recently made changes to their positions in the company. CWM LLC lifted its holdings in Semler Scientific by 486.3% during the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares during the last quarter. Bank of New York Mellon Corp increased its position in Semler Scientific by 10.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company’s stock worth $709,000 after buying an additional 1,940 shares during the period. Rhumbline Advisers lifted its holdings in shares of Semler Scientific by 27.1% during the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after buying an additional 1,320 shares in the last quarter. Quest Partners LLC bought a new stake in shares of Semler Scientific in the second quarter valued at about $59,000. Finally, Meeder Asset Management Inc. acquired a new position in shares of Semler Scientific in the second quarter valued at about $67,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Stock Performance

SMLR traded down $4.67 during trading hours on Friday, reaching $67.17. The company’s stock had a trading volume of 971,401 shares, compared to its average volume of 1,077,116. The company’s 50-day moving average is $43.82 and its 200-day moving average is $34.81. Semler Scientific has a 52 week low of $20.88 and a 52 week high of $79.45. The firm has a market cap of $556.84 million, a PE ratio of 32.77 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.35. The company had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.